ReviewMolecular nutrition & food research2026
Mechanistic Role of Disulfidptosis in Type 2 Diabetes Mellitus.
Review in Molecular nutrition & food research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disulfidptosis is a newly identified form of regulated cell death. It occurs under glucose-starvation conditions and is characterized by metabolic dysregulation in cells with high expression of SLC7A11. Increased cystine uptake under these conditions leads to depletion of NADPH, ultimately triggering cell death. Current research on disulfidptosis has mainly focused on malignant tumors. However, the critical factors involved in disulfidptosis, including high SLC7A11 expression and NADPH depletion, may have potential relevance to type 2 diabetes mellitus (T2DM). Both insulin secretion and insulin resistance are regulated by NADPH levels, and SLC7A11 also plays a key role in glucose metabolism through maintaining redox homeostasis. Although the direct connection between disulfidptosis and T2DM remains to be experimentally verified, this review integrates existing studies to systematically examine their theoretical relationship from both mechanistic and therapeutic perspectives. It focuses on the roles of SLC7A11, NADPH, and other related factors in T2DM and its complications, aiming to provide a theoretical basis for developing new treatment strategies for diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.